Another Ranbaxy Drug Plant Fails FDA Test
The U.S. Food and Drug Administration on Thursday barred drug products from a Ranbaxy Laboratories Inc. manufacturing plant in India from the U.S. market, the sixth company facility found to fail...To view the full article, register now.
Already a subscriber? Click here to view full article